Thomas Seufferlein is Professor of Gastroenterology at Ulm University, Germany.

He qualified in Medicine from the Technical University of Munich in 1989 and received his clinical training at the Free University of Berlin and Ulm University. From 1993-1996 he worked as a postdoc at the Imperial Cancer Research Fund, London. From 2008 until 2012 he was Head of the Department of Gastroenterology and Pneumology at the Martin-Luther-University Halle-Wittenberg. He has been Head of the Department of Gastroenterology, Endocrinology, Metabolism and Nephrology at Ulm University since 2012. Since 2019 he has been prodean for research at Ulm University Medical Faculty.

In addition to his general interest in Gastroenterology he has a particular interest in gastrointestinal oncology and is studying the molecular basis of GI cancers, in particular pancreatic cancer, and piloting the clinical use of novel treatments. Basic research interests include compartment specific signalling in cancer, regulation of cellular protein transport, tumour-host-interaction, organization of the tumour cell cytoskeleton and biomarkers.

Professor Seufferlein is member of the steering boards of the AIO colorectal and pancreatic cancer study groups, he coordinates the German National Guideline for pancreatic cancer and is involved in the ESMO guidelines for the diagnosis and treatment of pancreatic cancer. He is Editor-in-Chief of the German Journal of Gastroenterology and currently serves as President of the German Cancer Society.